The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Medipost
Seongnam-si, South Korea
A
- Employees
-
Key takeaway
MEDIPOST is a leader in stem cell therapeutics, having successfully commercialized CARTISTEM®, the world's first regulatory-approved allogeneic stem cell product for treating cartilage degeneration. The company is also advancing the development of stem cell treatments, including PNEUMOSTEM®, which is in clinical trials for bronchopulmonary dysplasia.
Reference
Service
Development Status - MEDIPOST
MEDIPOST stem cell treatment research and development status page. MEDIPOST succeeded in the commercialization of Cartistem, an allogeneic cord blood-derived mesenchymal stem cell treatment.
N-BIOTEK
Bucheon-si, South Korea
A
51-100 Employees
-
Key takeaway
N-BIOTEK is a leading company in life science and regenerative medicine, offering a comprehensive 'Stem Cell Total Solution' that includes bio cleanroom construction, equipment installation, and technology transfer. Their expertise and commitment to advancing stem cell culture technology position them as a key player in the field.
Reference
Product
Stem Cell Isolation Package - Lab Equipment - N-BIOTEK
N-BIOTEK
Clecell co.ltd
Seongnam-si, South Korea
A
11-50 Employees
2016
Key takeaway
The company, CLECELL, is innovating in the field of personalized and regenerative medicine through its advanced bioprinting and tissue engineering technologies. Their platform enables the creation of 3D cancer tissues and organoids, which could play a crucial role in the development and testing of new treatments.
Reference
Core business
CLECELL | Biotechnology company | South Korea
CLECELL is trailblazing the field of personalized and regenerative medicine with our revolutionary bioprinting and tissue engineering technology.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Spidercore Inc.
Daejeon, South Korea
A
1-10 Employees
2020
Key takeaway
Spidercore's S.Core platform focuses on enhancing gene therapy through advanced AI analysis of nucleotide properties, which is crucial for developing reliable gene-based treatments. Their commitment to improving biomedical decision-making and patient outcomes aligns with the innovative approaches in stem cell and gene therapy research.
Reference
Core business
Spidercore Inc.
Celltrion
Incheon, South Korea
A
501-1000 Employees
2002
Key takeaway
Celltrion is a global biopharmaceutical company that emphasizes its strong R&D capabilities and has established cGMP certified animal cell culture facilities. This expertise positions Celltrion as a key player in the biopharmaceutical industry, which may be relevant for advancements in stem cell research and applications.
Reference
Product
Technology
Cellumed
Seoul, South Korea
A
251-500 Employees
1997
Key takeaway
Cellumed's human tissue bank processes and distributes high-quality tissue grafts, continuously researching and developing tissue engineering products. Their focus on mRNA production enzymes and collaboration with leading CDMOs highlights their commitment to advancing biopharmaceuticals.
Reference
Core business
Cellumed
Femtobiomed
Seongnam-si, South Korea
A
11-50 Employees
2011
Key takeaway
FEMTOBIOMED is focused on advancing targeted gene delivery through multiplexed cell therapeutics, which could be relevant to stem cell research and applications.
Reference
Core business
FEMTOBIOMED
ProCell Therapeutics
Seoul, South Korea
A
1-10 Employees
2005
Key takeaway
ProCell is focused on becoming a leader in the biopharmaceutical sector, which may include advancements in areas like stem cell research and therapy.
Reference
Core business
프로셀테라퓨틱스
MITT,MTD,거대분자세포내전송기술보유,신약개발,바이오벤처기업,피투스킨,성장인자원료,기능성화장품,OEM,ODM
MxT Biotech
Seoul, South Korea
A
1-10 Employees
2021
Key takeaway
MxT Biotech is advancing the field of cellular engineering and genome editing through its Hydroporator® platform, which enables highly effective delivery of various genetic materials into primary cells. This technology is particularly relevant for applications in stem cell research and therapy.
Reference
Core business
MxT Biotech :: Microfluidics x Therapy
We transform cancer immunotherapy, cellular engineering and genome editing with our patented non-viral genome editing technology, Hydroporator .
ReMedium Korea
Seoul, South Korea
A
11-50 Employees
-
Key takeaway
ReMedium is dedicated to innovation and scientific excellence in the aesthetic industry, offering a diverse range of products, including facial injectables and skin care solutions, all backed by rigorous clinical trials. Their commitment to research and development ensures that their offerings meet the evolving needs of clients while maintaining a strong foundation in scientific credibility.
Reference
Core business
Remedium - Remedium Korea
ReMedium, We Manufacture the best Korean Fillers, Threads and other medical devices.ReMedium products are made from Korea and have completed the clinical trials at the Seoul National University Hospital.
Technologies which have been searched by others and may be interesting for you:
The stem cell industry in South Korea presents a dynamic landscape characterized by several key considerations. First, regulatory frameworks play a crucial role; the country has established comprehensive guidelines to ensure ethical practices and safety in stem cell research and therapies. Understanding these regulations is essential for anyone looking to engage with local companies. Additionally, researchers and investors should be aware of the challenges, such as public perception and potential ethical dilemmas surrounding stem cell use, which can influence market acceptance and funding opportunities. Opportunities abound in South Korea, as it is home to a robust biotechnology sector, strong government support, and significant investment in research and development, positioning the country as a leader in stem cell innovation. The competitive landscape includes numerous local firms and international players, making collaboration and networking vital for success. Furthermore, environmental concerns related to biotechnology practices should not be overlooked, as sustainability is becoming increasingly important in the industry. Lastly, the global market relevance of South Korea's stem cell sector is notable, with an increasing number of partnerships and collaborations internationally, indicating a growing influence on global healthcare solutions. Understanding these aspects will provide valuable insights for anyone interested in navigating the stem cell industry in South Korea.
Some interesting numbers and facts about your company results for Stem Cell
| Country with most fitting companies | South Korea |
| Amount of fitting manufacturers | 12 |
| Amount of suitable service providers | 3 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1997 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Stem Cell
What are related technologies to Stem Cell?
Based on our calculations related technologies to Stem Cell are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Stem Cell?
Start-Ups who are working in Stem Cell are MxT Biotech
Which industries are mostly working on Stem Cell?
The most represented industries which are working in Stem Cell are Biotechnology, Medical, Other, Healthcare, IT, Software and Services
How does ensun find these Stem Cell Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
